Introduction
When Senators Ron Wyden and Jeff Merkley of Oregon reintroduced the Cannabinoid Safety and Regulation Act (CSRA) in December 2025, they offered the hemp industry something it had been asking for since 2018: a federal regulatory framework for hemp-derived cannabinoids that treats them like the consumer products they are — with safety standards, age restrictions, testing requirements, and labeling rules — rather than simply banning them.
The CSRA is the most substantive legislative alternative to the November 12, 2026 intoxicating hemp product restrictions currently on the table in Congress. At 84 pages, it is not a delay bill — it is a replacement framework. And whether or not it passes, understanding what it proposes matters for every hemp manufacturer trying to understand where federal hemp policy is heading.
This article breaks down what the CSRA would actually do, how it differs from the current November 12 standard, and what it means for B2B hemp ingredient buyers and manufacturers.
What the CSRA Would Create
The CSRA's core structure is a federal regulatory framework for hemp-derived cannabinoid products administered by the FDA, with the following key provisions:
THC limits by product format:
- Edibles and ingestible products: 5 milligrams of total THC per serving, 50 milligrams per container
- Beverages: 5 milligrams per serving, 10 milligrams per container
- This is dramatically more permissive than the current November 12 standard of 0.4mg per container — but it comes with a regulatory structure that does not currently exist
Age restrictions: A federal minimum purchase age of 21, enforced at the point of sale. Hemp-derived cannabinoid products could not legally be sold to anyone under 21.
Mandatory third-party testing: All hemp-derived cannabinoid products would be required to undergo third-party testing and carry a QR code or scannable label linking consumers to lab results. COA transparency would be built into the law.
Standardized labeling: Requirements for standardized serving size disclosure, total cannabinoid content, warnings, and ingredient disclosure.
Synthetic cannabinoid restrictions: The CSRA explicitly targets synthetic and chemically derived cannabinoids — delta-8, delta-10, HHC produced through chemical conversion — which would remain restricted under the framework.
Pesticide, heavy metal, and contaminant limits: Federal safety standards for hemp-derived products, filling the regulatory gap that has allowed contaminated products to reach market.
How the CSRA Differs From November 12
The November 12, 2026 standard — set by the government funding deal of November 2025 — establishes a single threshold: 0.4mg of total THC per finished product container. Products above that threshold are federally unlawful regardless of format, ingredients, or labeling.
The CSRA would replace that blunt threshold with a graduated, format-specific framework. A 10mg beverage would be lawful under CSRA. It is non-compliant under November 12. A 50mg edible container would be lawful under CSRA. It is non-compliant under November 12.
For the hemp consumer product market, the CSRA framework is substantially more accommodating — but it comes with trade-offs. Age verification, mandatory testing, standardized labeling, and FDA oversight are real compliance costs that many smaller hemp operators are not currently equipped to meet.
For B2B hemp ingredient suppliers, the CSRA would mean a larger addressable market for hemp-derived cannabinoid ingredients — but one with more rigorous documentation and testing requirements.
Does the CSRA Have a Path Forward?
The honest answer is: uncertain. The CSRA was introduced by two Democratic senators from Oregon. The Republican-controlled Senate has shown limited appetite for hemp consumer product regulation — the November 2025 restrictions were inserted by Republican Senate appropriators specifically because they viewed the unregulated hemp market as a loophole that needed closing.
For the CSRA to pass, it would need bipartisan Senate support, House companion legislation, and a legislative vehicle — none of which exist in a defined form right now. The 2026 Farm Bill's advancement without any delay or modification to the November 12 standard in the House reduces the near-term path further.
The CSRA matters not primarily as a likely near-term legislative outcome, but as a signal of where federal hemp regulation eventually needs to go: a framework that distinguishes between intoxicating products and wellness products, creates enforceable safety standards, and treats hemp as a legitimate regulated industry rather than a prohibition target.
What This Means for B2B Hemp Operators
For manufacturers currently planning for November 12, the CSRA does not change the operational calculus. Plan for 0.4mg/container. The CSRA has not passed, its passage is uncertain, and the November 12 deadline is not contingent on it.
What the CSRA does usefully demonstrate is that the political will for a regulated hemp market — rather than a prohibited one — exists in some form. The post-November landscape is unlikely to remain static. A compliant hemp ingredient supply chain built for the 0.4mg/container standard is also a supply chain built for more permissive future frameworks, because compliant ingredients are compliant under any standard.
Low Gravity Hemp Perspective
We follow the CSRA closely because it represents the regulatory model we believe the hemp industry needs: safety standards, transparency requirements, and age restrictions that distinguish legitimate hemp wellness from unregulated intoxication. Whether or not the CSRA passes, our ingredient specifications — rigorous documentation, third-party testing, total THC compliance — are designed for a regulated industry, not an unregulated one.
Our B2B customers who build for 0.4mg/container compliance today will be positioned for any future regulatory framework. They're building the infrastructure of a legitimate, defensible hemp supply chain regardless of what Congress does next.
Final Thoughts
The CSRA is the most substantive alternative to the November 12 framework in Congress. Whether it passes or not, understanding its structure helps hemp operators understand the direction federal policy is moving — and why building a compliant, documented supply chain now is the right strategy under any scenario.
👉 Visit lowgravityhemp.com to explore our compliance-ready cannabinoid ingredient portfolio and join the manufacturers building for the regulated hemp future.
